Insulinoma Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: IADBF1C64DECEN
Market Monitor Global

Abstracts

An insulinoma is a tumor of the pancreas that is derived from beta cells and secretes insulin. It is a rare form of a neuroendocrine tumor. Most insulinomas are benign in that they grow exclusively at their origin within the pancreas.

This report contains market size and forecasts of Insulinoma in Global, including the following market information:

Global Insulinoma Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Insulinoma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Benign Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Insulinoma include Abcam, Ciron Group, Pfizer, Entax Medical, Olympus, Boston Scientific Corporation, Medtronic and Cook Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insulinoma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Insulinoma Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Insulinoma Market Segment Percentages, by Type, 2021 (%)

• Benign
• Metastatic

Global Insulinoma Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Insulinoma Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Research and Academic Institutions
• Biotechnology and Pharmaceutical Companies

Global Insulinoma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Insulinoma Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Insulinoma revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Insulinoma revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abcam
• Ciron Group
• Pfizer
• Entax Medical
• Olympus
• Boston Scientific Corporation
• Medtronic
• Cook Medical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Insulinoma Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Insulinoma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INSULINOMA OVERALL MARKET SIZE

2.1 Global Insulinoma Market Size: 2021 VS 2028
2.2 Global Insulinoma Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Insulinoma Players in Global Market
3.2 Top Global Insulinoma Companies Ranked by Revenue
3.3 Global Insulinoma Revenue by Companies
3.4 Top 3 and Top 5 Insulinoma Companies in Global Market, by Revenue in 2021
3.5 Global Companies Insulinoma Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insulinoma Players in Global Market
  3.6.1 List of Global Tier 1 Insulinoma Companies
  3.6.2 List of Global Tier 2 and Tier 3 Insulinoma Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Insulinoma Market Size Markets, 2021 & 2028
  4.1.2 Benign
  4.1.3 Metastatic
4.2 By Type - Global Insulinoma Revenue & Forecasts
  4.2.1 By Type - Global Insulinoma Revenue, 2017-2022
  4.2.2 By Type - Global Insulinoma Revenue, 2023-2028
  4.2.3 By Type - Global Insulinoma Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Insulinoma Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Research and Academic Institutions
  5.1.5 Biotechnology and Pharmaceutical Companies
5.2 By Application - Global Insulinoma Revenue & Forecasts
  5.2.1 By Application - Global Insulinoma Revenue, 2017-2022
  5.2.2 By Application - Global Insulinoma Revenue, 2023-2028
  5.2.3 By Application - Global Insulinoma Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Insulinoma Market Size, 2021 & 2028
6.2 By Region - Global Insulinoma Revenue & Forecasts
  6.2.1 By Region - Global Insulinoma Revenue, 2017-2022
  6.2.2 By Region - Global Insulinoma Revenue, 2023-2028
  6.2.3 By Region - Global Insulinoma Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Insulinoma Revenue, 2017-2028
  6.3.2 US Insulinoma Market Size, 2017-2028
  6.3.3 Canada Insulinoma Market Size, 2017-2028
  6.3.4 Mexico Insulinoma Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Insulinoma Revenue, 2017-2028
  6.4.2 Germany Insulinoma Market Size, 2017-2028
  6.4.3 France Insulinoma Market Size, 2017-2028
  6.4.4 U.K. Insulinoma Market Size, 2017-2028
  6.4.5 Italy Insulinoma Market Size, 2017-2028
  6.4.6 Russia Insulinoma Market Size, 2017-2028
  6.4.7 Nordic Countries Insulinoma Market Size, 2017-2028
  6.4.8 Benelux Insulinoma Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Insulinoma Revenue, 2017-2028
  6.5.2 China Insulinoma Market Size, 2017-2028
  6.5.3 Japan Insulinoma Market Size, 2017-2028
  6.5.4 South Korea Insulinoma Market Size, 2017-2028
  6.5.5 Southeast Asia Insulinoma Market Size, 2017-2028
  6.5.6 India Insulinoma Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Insulinoma Revenue, 2017-2028
  6.6.2 Brazil Insulinoma Market Size, 2017-2028
  6.6.3 Argentina Insulinoma Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Insulinoma Revenue, 2017-2028
  6.7.2 Turkey Insulinoma Market Size, 2017-2028
  6.7.3 Israel Insulinoma Market Size, 2017-2028
  6.7.4 Saudi Arabia Insulinoma Market Size, 2017-2028
  6.7.5 UAE Insulinoma Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abcam
  7.1.1 Abcam Corporate Summary
  7.1.2 Abcam Business Overview
  7.1.3 Abcam Insulinoma Major Product Offerings
  7.1.4 Abcam Insulinoma Revenue in Global Market (2017-2022)
  7.1.5 Abcam Key News
7.2 Ciron Group
  7.2.1 Ciron Group Corporate Summary
  7.2.2 Ciron Group Business Overview
  7.2.3 Ciron Group Insulinoma Major Product Offerings
  7.2.4 Ciron Group Insulinoma Revenue in Global Market (2017-2022)
  7.2.5 Ciron Group Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Insulinoma Major Product Offerings
  7.3.4 Pfizer Insulinoma Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Entax Medical
  7.4.1 Entax Medical Corporate Summary
  7.4.2 Entax Medical Business Overview
  7.4.3 Entax Medical Insulinoma Major Product Offerings
  7.4.4 Entax Medical Insulinoma Revenue in Global Market (2017-2022)
  7.4.5 Entax Medical Key News
7.5 Olympus
  7.5.1 Olympus Corporate Summary
  7.5.2 Olympus Business Overview
  7.5.3 Olympus Insulinoma Major Product Offerings
  7.5.4 Olympus Insulinoma Revenue in Global Market (2017-2022)
  7.5.5 Olympus Key News
7.6 Boston Scientific Corporation
  7.6.1 Boston Scientific Corporation Corporate Summary
  7.6.2 Boston Scientific Corporation Business Overview
  7.6.3 Boston Scientific Corporation Insulinoma Major Product Offerings
  7.6.4 Boston Scientific Corporation Insulinoma Revenue in Global Market (2017-2022)
  7.6.5 Boston Scientific Corporation Key News
7.7 Medtronic
  7.7.1 Medtronic Corporate Summary
  7.7.2 Medtronic Business Overview
  7.7.3 Medtronic Insulinoma Major Product Offerings
  7.7.4 Medtronic Insulinoma Revenue in Global Market (2017-2022)
  7.7.5 Medtronic Key News
7.8 Cook Medical
  7.8.1 Cook Medical Corporate Summary
  7.8.2 Cook Medical Business Overview
  7.8.3 Cook Medical Insulinoma Major Product Offerings
  7.8.4 Cook Medical Insulinoma Revenue in Global Market (2017-2022)
  7.8.5 Cook Medical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Insulinoma Market Opportunities & Trends in Global Market
Table 2. Insulinoma Market Drivers in Global Market
Table 3. Insulinoma Market Restraints in Global Market
Table 4. Key Players of Insulinoma in Global Market
Table 5. Top Insulinoma Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Insulinoma Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Insulinoma Revenue Share by Companies, 2017-2022
Table 8. Global Companies Insulinoma Product Type
Table 9. List of Global Tier 1 Insulinoma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulinoma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Insulinoma Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Insulinoma Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Insulinoma Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Insulinoma Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Insulinoma Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Insulinoma Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Insulinoma Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Insulinoma Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Insulinoma Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Insulinoma Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Insulinoma Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Insulinoma Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Insulinoma Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Insulinoma Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Insulinoma Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Insulinoma Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Insulinoma Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Insulinoma Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Insulinoma Revenue, (US$, Mn), 2023-2028
Table 30. Abcam Corporate Summary
Table 31. Abcam Insulinoma Product Offerings
Table 32. Abcam Insulinoma Revenue (US$, Mn), (2017-2022)
Table 33. Ciron Group Corporate Summary
Table 34. Ciron Group Insulinoma Product Offerings
Table 35. Ciron Group Insulinoma Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Insulinoma Product Offerings
Table 38. Pfizer Insulinoma Revenue (US$, Mn), (2017-2022)
Table 39. Entax Medical Corporate Summary
Table 40. Entax Medical Insulinoma Product Offerings
Table 41. Entax Medical Insulinoma Revenue (US$, Mn), (2017-2022)
Table 42. Olympus Corporate Summary
Table 43. Olympus Insulinoma Product Offerings
Table 44. Olympus Insulinoma Revenue (US$, Mn), (2017-2022)
Table 45. Boston Scientific Corporation Corporate Summary
Table 46. Boston Scientific Corporation Insulinoma Product Offerings
Table 47. Boston Scientific Corporation Insulinoma Revenue (US$, Mn), (2017-2022)
Table 48. Medtronic Corporate Summary
Table 49. Medtronic Insulinoma Product Offerings
Table 50. Medtronic Insulinoma Revenue (US$, Mn), (2017-2022)
Table 51. Cook Medical Corporate Summary
Table 52. Cook Medical Insulinoma Product Offerings
Table 53. Cook Medical Insulinoma Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Insulinoma Segment by Type in 2021
Figure 2. Insulinoma Segment by Application in 2021
Figure 3. Global Insulinoma Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insulinoma Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insulinoma Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insulinoma Revenue in 2021
Figure 8. By Type - Global Insulinoma Revenue Market Share, 2017-2028
Figure 9. By Application - Global Insulinoma Revenue Market Share, 2017-2028
Figure 10. By Region - Global Insulinoma Revenue Market Share, 2017-2028
Figure 11. By Country - North America Insulinoma Revenue Market Share, 2017-2028
Figure 12. US Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Insulinoma Revenue Market Share, 2017-2028
Figure 16. Germany Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 17. France Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Insulinoma Revenue Market Share, 2017-2028
Figure 24. China Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 28. India Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Insulinoma Revenue Market Share, 2017-2028
Figure 30. Brazil Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Insulinoma Revenue Market Share, 2017-2028
Figure 33. Turkey Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Insulinoma Revenue, (US$, Mn), 2017-2028
Figure 37. Abcam Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ciron Group Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Entax Medical Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Olympus Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boston Scientific Corporation Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Medtronic Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cook Medical Insulinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)